Opaleye Management Inc.

Position in DERM — Journey Medical Corp

CIK 1595855 Boston, MA

Position in DERM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,502,400

-$3,014,850 QoQ

Shares Held

960,000

-1.5% QoQ

Ownership

3.49%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Opaleye Management Inc. holds $276,064,304 across 5 Drug Manufacturers - Specialty & Generic names. DERM ranks #5 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	2,832,230	$99,864,429
2	LQDA	Liquidia Corp	2,545,000	$96,048,300
3	ETON	Eton Pharmaceuticals, Inc.	2,860,000	$70,584,800
4	ASRT	Assertio Holdings, Inc.	265,707	$5,064,375
5	DERM	Journey Medical Corp This page	960,000	$4,502,400

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,502,400	960,000	-1.5%	Shares	Sole	2026-05-15
2025-12-31	$7,517,250	975,000	+0.4%	Shares	Sole	2026-04-13
2025-09-30	$6,913,975	971,064	+922.2%	Shares	Sole	2025-11-14
2025-06-30	$682,100	95,000	+37.0%	Shares	Sole	2025-08-15
2025-03-31	$409,005	69,323	-73.3%	Shares	Sole	2025-05-15
2022-09-30	$637,860	259,293	+5.5%	Shares	Sole	2022-11-14
2022-06-30	$919,041	245,733	+266.8%	Shares	Sole	2022-08-15
2022-03-31	$323,610	67,000	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.